Clinical Trials Browser

Phase 2 × Active not recruiting × Artesunate × Clear all

NCT07022743 2025-09-05

Improving Treatment Outcomes in Chronic Myeloid Leukaemia Patients Using Imatinib and Artesunate Combination Therapy

Phase 2 Active not recruiting

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT05555862 2025-05-18

anal HSIL HIV-

Phase 2 Active not recruiting

Papillomavirus Infections